Stemetil (Prochlorperazine) Dosing
For adults with nausea and vomiting, the standard dose of prochlorperazine (Stemetil) is 5-10 mg orally three to four times daily, with a maximum of 40 mg per day, or 25 mg as a suppository with a maximum of three doses per 24 hours. 1, 2
Adult Dosing by Indication
Nausea and Vomiting
- Oral tablets: 5-10 mg three to four times daily 2
- Maximum daily dose: 40 mg for resistant cases 2
- Rectal suppository: 25 mg, maximum three doses per 24 hours 1
- Intravenous: 2.5 mg by slow IV push has been shown effective and safe, particularly in acute settings 3
- Begin with the lowest recommended dosage and adjust based on individual response 2
Migraine-Associated Nausea (Adjunctive Therapy)
- Standard dose: 25 mg orally or by suppository 1
- Maximum: Three doses per 24 hours 1
- Administer 20-30 minutes before or with analgesics, NSAIDs, or ergotamine derivatives 1
Psychiatric Disorders
- Non-psychotic anxiety: 5 mg three to four times daily 2
- Psychotic disorders/schizophrenia: 5-10 mg three to four times daily initially, titrating to 100-150 mg daily for severe cases 2
Pediatric Dosing
Critical Safety Warning
Prochlorperazine should NOT be used in children under 20 pounds (9 kg) or under 2 years of age, and should NOT be used in pediatric surgery. 2 Children are more prone to extrapyramidal reactions even at moderate doses 2, 4
Nausea and Vomiting in Children (Weight-Based)
- 20-29 lbs (9-13 kg): 2.5 mg once or twice daily, maximum 7.5 mg/day 2
- 30-39 lbs (14-18 kg): 2.5 mg two to three times daily, maximum 10 mg/day 2
- 40-85 lbs (18-39 kg): 2.5 mg three times daily OR 5 mg twice daily, maximum 15 mg/day 2
- More than one day of therapy is seldom necessary 2
Schizophrenia in Children (Ages 2-12)
- Starting dose: 2.5 mg two to three times daily 2
- Maximum first day: 10 mg 2
- Ages 2-5: Total daily dose usually does not exceed 20 mg 2
- Ages 6-12: Total daily dose usually does not exceed 25 mg 2
Special Populations
Elderly Patients
- Use dosages in the lower range 2
- Elderly patients are more susceptible to hypotension and neuromuscular reactions 2
- Increase dosage more gradually and monitor response carefully 2
Debilitated or Emaciated Patients
Key Safety Considerations
Common Adverse Effects
- Sedation: Occurs in approximately 10% of patients receiving multiple doses 5
- Extrapyramidal symptoms (EPS): Occur in 4-9% of patients 5
- Prochlorperazine causes significantly less sleepiness compared to promethazine (38% versus 71%) 6
Serious Adverse Effects (Rare)
- Seizures, neuroleptic malignant syndrome, autonomic collapse, tardive dyskinesia 5
- Akathisia, pseudo-parkinsonism, dystonia 1
- Hypotension, tachycardia, arrhythmias 1
Contraindications
- CNS depression 1
- Use of adrenergic blockers 1
- Pheochromocytoma 1
- Seizure disorders 1
- GI bleeding or obstruction 1
- Children under 20 pounds or under 2 years of age 2
Clinical Pearls
Efficacy
- Prochlorperazine demonstrates superior efficacy compared to promethazine for nausea and vomiting, with faster time to complete relief (30-60 minutes) and fewer treatment failures (9.5% versus 31%) 6
- In real-world Indian practice, prochlorperazine at a mean dose of 14.9 mg/day for 7.2 days was well-tolerated with only 0.6% adverse drug reaction rate 7
Administration Considerations
- Extrapyramidal symptoms are independent of dosage in children 4
- Dystonic reactions can be immediately reversed with intramuscular orphenadrine 4
- Take particular precaution in children with acute illnesses or dehydration 2
- Tell parents not to exceed prescribed dosage, as adverse reaction risk increases with higher doses 2